SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-17-011827
Filing Date
2017-11-27
Accepted
2017-11-27 16:01:21
Documents
7
Period of Report
2017-11-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kq317earningsrelease.htm 8-K 32123
2 EXHIBIT 99.1 a3q17earningsreleasefina.htm EX-99.1 15845
3 a3q17earningsreleasefina001.jpg GRAPHIC 220909
4 a3q17earningsreleasefina002.jpg GRAPHIC 251966
5 a3q17earningsreleasefina003.jpg GRAPHIC 222871
6 a3q17earningsreleasefina004.jpg GRAPHIC 108223
7 optinoselogorgb.jpg GRAPHIC 10067
  Complete submission text file 0001628280-17-011827.txt   1167393
Mailing Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067
Business Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Filer) CIK: 0001494650 (see all company filings)

IRS No.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38241 | Film No.: 171222921
SIC: 2834 Pharmaceutical Preparations